Coherus BioSciences
CHRS
#9152
Rank
HK$1.40 B
Marketcap
HK$9.10
Share price
-0.85%
Change (1 day)
26.06%
Change (1 year)

Market capitalization of Coherus BioSciences (CHRS)

Market cap: HK$1.40 Billion

As of August 2026 Coherus BioSciences has a market cap of HK$1.40 Billion. This makes Coherus BioSciences the world's 9152th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Coherus BioSciences from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.40 B12.44%
2025HK$1.25 B-6.15%
2024HK$1.33 B-53.98%
2023HK$2.89 B-39.82%
2022HK$4.81 B-49.63%
2021HK$9.55 B-1.56%
2020HK$9.70 B-1.62%
2019HK$9.86 B103.84%
2018HK$4.84 B19.9%
2017HK$4.03 B-57.63%
2016HK$9.52 B37.28%
2015HK$6.94 B64.88%
2014HK$4.20 B

End of Day market cap according to different sources

On Aug 12th, 2026 the market cap of Coherus BioSciences was reported to be:

HK$1.41 Billion
by Nasdaq info icon info icon
HK$1.41 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
HK$1.769 T 125,752.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$74.00 B 5,161.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.44 M-99.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$48.38 B 3,340.07%๐Ÿ‡บ๐Ÿ‡ธ USA